Experts from the National Autonomous University of Mexico (UNAM) are using the natural process of light emission from fireflies to identify the effectiveness of some cancer drugs.
To shine, fireflies produce luciferin, a substrate that, upon contact with an oxidative enzyme called luciferase, emits light. This is called bioluminescence, explained the expert from the Institute of Biotechnology (IBt) of the National Autonomous University of Mexico (UNAM), Luis Covarrubias, with whom Celina García and Verónica Rojo are collaborating.
The academic uses the facilities of the National Laboratory of Advanced Microscopy (LNMA) of IBt where they have the special equipment to detect bioluminescence, acquired through donations from the National Council of Science and Technology and UNAM’s Coordination of Scientific Research.
Covarrubias explained that in his research the first possibility is to introduce luciferase into tumor cells that will then be implemented in mice, in order to allow them to grow. The next step is to apply luciferin, “in order to see the growth of the tumor, because as it enlarges the luminescence becomes greater. And then, by administering an effective anticancer, the light will shrink. ”
The strategy of the research team is to create cells with tumorigenic potential containing firefly genes, in this way the cancer cells will shine as they grow.
“We use cell lines derived from human tumors and we introduce the gene that codes for luciferase. This allows to test drugs against cancer directly in human cells, which grow inside an immunodeficient animal”, the academic said.
The second possibility is to use transgenic mice, which have been modified so that their organism distributes luciferase activity when an intracellular signaling pathway associated with cervical cancer is switched on.
To achieve this, the researcher acquired transgenic mice in which the production of luciferase is linked to this pathway. These animals were genetically combined with other transgenic rodents, produced some years ago in their laboratory by microinjection of papillomavirus oncogenes.
In these double-transgenic mice it can be observed that, either by the presence of the oncogenes of the papillomavirus, by the hormone estradiol or by both, the area of the cervix begins to shine. In this genetic and hormonal combination the tissues bioluminate and this is how the LNMA teams detect the start of the tumor.
TYT Newsroom with information from http://www.gaceta.unam.mx/
more recommended stories
Pentagon extends mission to Mexico border through September
WASHINGTON (Reuters) – The U.S. military.
‘El Chapo’ paid former Mexican president Peña Nieto $100 million bribe: trial witness
Jan 15 (Reuters) – Accused Mexican.
3 Tips That Will Make Your Stay in Yucatán More Enjoyable
Yucatán has always been one of.
Unstoppable damage to the mangrove systems in Yucatan, new ecocide in Ría Lagartos
In an area of 2, 500.
Cancun Welcomes Swoop’s Inaugural Flight from Toronto Hamilton Airport
Three destinations in Mexico departing out.
More and more accidents involving motorcycle drivers in Yucatán
“During the first 13 days of.
Rolando Zapata personally responds to accusations against him
In a three-minute video he recorded.
Two cases of sexual abuse in the same night in Mérida
Despite campaigns to stop gender-based violence.
First Ecological Police in the state of Yucatan
PROGRESO, YUCATÁN.- At the Coordinated Municipal.
Tons of sargassum to invade Yucatan And Quintana Roo beaches in 2019
YUCATAN MEXICO.- Tons of sargassum infest.